Kelly Wright

Kelly Wright is a seasoned professional in the pharmaceutical and biotechnology sectors with extensive experience in market access, national accounts, and oncology. Currently serving as the Director of National Accounts at ImmunoGen, Inc., Kelly is instrumental in the commercial launch of ELAHERE, an FDA-approved antibody-drug conjugate for platinum-resistant ovarian cancer. As the founder of the Market Access Account Leadership Network, Kelly provides consulting and mentorship while tracking healthcare reimbursement trends. Previous roles include National Accounts Director positions at Gilead Sciences and Lupin Pharmaceuticals, where Kelly facilitated market access for innovative therapies. Kelly's career began in sales and management roles at Amgen, Kendall Healthcare, and Hoechst-Roussel Pharmaceuticals, earning recognition for outstanding performance and strategic contributions. Kelly holds a Bachelor's degree in Business from California State University-Sacramento.